alt Hacker NewsIt's pretty painful watching CS try to turn biology into an engineering problem.
It's generally very easy to marginally move the needle in drug discovery. It's very hard to move the needle enough to justify the cost.
What is challenging is culling ideas, and having enough SNR in your readouts to really trust them.
> It's generally very easy to marginally move the needle in drug discovery. It's very hard to move the needle enough to justify the cost.
Maybe this kind of AI-based exploration would lower the costs. The more something is automated, the cheaper it should be to test many concepts in parallel.